One of Clint Eastwood's most underrated directorial efforts features a comeback from The Good the Bad and the Ugly's ...

The Wallach Biovac Smoke Evacuator efficiently removes airborne vapor containing potentially harmful microbes and viruses. It features a high-powered motor and a disposable, one-piece filter that ...

With the modern resurgence of Westerns, it is worth looking back at the classic films that define the genre and still ...

To QB or not to QB? That was the question Eli Stowers asked himself as the 2023 college football season approached for New Mexico State. The question answered itself. The answer not to QB.

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

The Employee Provident Fund Organisation (EPFO) has extended the deadline to January 15, 2024, for UAN activation and seeding of your bank account with Aadhaar for availing of the benefits under the ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate ...

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder. The weekly injection is now ...

In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

The US Food and Drug Administration (FDA) has stood by an earlier decision confirming that the tirzepatide shortage is over. The end of the shortage means that pharmacies making compounded ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US regulators have approved Eli Lilly’s Zepbound to treat adults with both sleep apnoea and obesity ...

Many patients seeking glucagon-like peptide-1 receptor agonists (GLP-1RAs) turned to compound pharmacies as demand for Eli Lilly’s tirzepatide, branded as Ozempic and Mounjaro, far-outpaced supply, ...